Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Cryoblation for Menorrhagia Cleared by FDA

By HospiMedica staff writers
Posted on 02 May 2001
A cryosurgical system for endometrial ablation in pre-menopausal women with excessive menstrual bleeding due to benign causes has been cleared by the U.S. More...
Food and Drug Administration (FDA).

The system is called Her Option. A slender probe attached to a cooling unit is inserted through the cervix into the uterus. Then the tip of the probe is brought to a very low temperature to freeze and eliminate the uterine lining. The system uses a unique closed-cycle cryogenic gas-cooling unit the size of a desktop computer to cool the tip of the probe. The procedure is guided and monitored on a real-time basis using ultrasound. The system was developed by CryoGen, Inc. (San Diego, CA, USA).

"The Her Option procedure offers a safe and effective, less-invasive alternative to hysterectomy for women who have completed childbearing,” said Seth J. Herbst, M.D., of the Institute for Women's Health (West Palm Beach, FL, USA). "It can be performed with a local anesthetic in a hospital, surgery center, or physician's office in approximately 20 minutes.”

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Imaging Table
Stille imagiQ2
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.